Mon, 01 Aug 2011 | BUSINESS SALE
Chiltern International, the Slough-based clinical research group, is being put up for auction with a price tag in excess of £200 million, according to reports.
Mergermarket reported that the Berkshire company, which has a global workforce of more than 1,300 staff, is being sold by current owners, the private investment firm Czura Thornton. It is said to have appointed Goldman Sachs to explore auctioning off the business, in the hope of doubling the investment the firm made in the company when it purchased Chiltern five years ago. It has been claimed that Chiltern has been up for sale for the last six months.
No official statement has yet been made by Chiltern, but it is thought that potential bidders for the company could include CCMP Capital Advisors. CCMP has recently bought the smaller US-based firm, Medpace, and is looking to expand its footprint in Europe.
Since being founded in 1982, Chiltern International has become one of the world's top contract research organisations, conducting research at bases in more than 40 countries across the globe. It provides full clinical research services, including global clinical development, biometric, and medical and regulatory affairs. Its revenue for the year ending March 2009 was £80.9 million and EBITDA was £9 million, according to a previous report.
For sale is a long-established tree surgery and arboricultural services business with an excellent reputation, serving both domestic and commercial sectors across Southern England, including the Home Counties and London.
An opportunity has arisen to acquire a mechanical engineering company specialising in the Water Industry. Benefitting from over 3 decades of trading, this business has built a solid and long standing client base comprised of prominent UK utility comp...
An opportunity has arisen to acquire a reputable IT support and development services provider with a UK-wide client base and a proven record for innovation and resilience in the constantly evolving IT sector. Throughout its 25+ year trading history,...
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.